BLOOD-BASED EXOSOMAL A-SYNUCLEIN AGGREGATES AS A QUANTIFIABLE BIOMARKER OF PARKINSON'S DISEASE. NEW AWARD.

Iowa City Va Medical Research Foundation

Investigators